{"indicator_number":"SOC3-2-2","goal_number":"SOC3","goal_name":"global_goals.SOC3-title","target_number":"SOC3-2","target_name":"global_targets.SOC3-2-title","indicator_name":"indicators.SOC3-2-2-title","PillarCode":"SOC","PillarDescription":"pillars.SOC","GoalId":"SOC3","GoalDescription":"global_goals.SOC3-title","PolicyObjectiveId":"SOC3-2","PolicyObjectiveDescription":"global_targets.SOC3-2-title","IndicatorId":"SOC3-2-2","IndicatorDescription":"indicators.SOC3-2-2-title","national_geographical_coverage":"Vanuatu","TargetDescription":" By 2020, the incidence of TB in Vanuatu has reduced by 20% compared to 2015 \n By 2025-50% reduction \n By 2030- 80% reduction","SDGAlignment":"","Definition":"The tuberculosis incidence per 100,000 population as defined as the estimated number of new and relapse TB cases (all forms of TB, including cases in people living with HIV) arising in a given year, expressed as a rate per 100 000 population.","Concept":"Direct measurement requires high-quality surveillance systems in which underreporting is negligible, and strong health systems so that under-diagnosis is also negligible; otherwise indirect estimates are based on notification data and estimates of levels of underreporting and under-diagnosis.","Rationale":"The overall goal is to \u201cEnd the global tuberculosis epidemic\u201d, and correspondingly ambitious targets for reductions in tuberculosis deaths and cases are set for 2030 (80% reduction in incidence rate compared with the level of 2015) and 2035 (90% reduction in incidence rate), in the context of the SDGs.","ComputationMethod":"(number of TB incidence) / (total pop) X 100","ComputationUnit":"Percentage (%)","Proxy":"Yes","Disaggregation":"\u2022  Age\n\u2022 Geographic location\n\u2022 Sex","DataSource":"Health Information System  (HIS)","FrequencyOfCollection":"Monthly & Annually","source_organisation_1":"Vanuatu Ministry of Health - Health Data, TB/Leprosy Unit (from M&E framework)","source_organisation_2":"","source_organisation_3":"","national_metadata_updated_date":"2021-06-09","national_data_updated_date":"2023-05-29","composite_breakdown_label":"","computation_units":"","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":[],"footer_fields":[],"graph_annotations":[],"graph_limits":[],"graph_series_breaks":[],"graph_stacked_disaggregation":"","graph_target_lines":[],"graph_title":"Incidence of TB (per 100,000 population)","graph_titles":[],"graph_type":"bar","indicator_available":"","indicator_tabs":{"override":false,"tab_1":"","tab_2":"","tab_3":"","tab_4":""},"page_content":"","permalink":"","placeholder":"","precision":[],"progress_status":"not_available","proxy":"","proxy_series":[],"publications":[],"related_indicators":[],"reporting_status":"complete","sort":"","sources":[],"standalone":false,"tags":[],"x_axis_label":"Years","progress":[{"target":"progress.target1","years":[{"year":2021,"status":"progress.cloudy","image":"cloudy.png"}]}],"indicator_sort_order":"SOC3-02-02"}